27.07.2011 • NewsQ2 2011sales and profitsPraxair

Praxair Q2 Profit Rises

Praxair Wednesday said net income in the second quarter increased to $425 million or $1.38 per share from $371 million or $1.19 per share in the prior year.

On average, 16 analysts polled by Thomson Reuters expected the company to earn $1.37 per share in the quarter. Analysts' estimates typically exclude special items.

Sales increased 13% to $2.86 billion from $2.53 billion, surpassing Wall Street view of $2.79 billion.

For the third quarter, Praxair expects earnings per share in the range of $1.35 to $1.40. Analysts expect earnings of $1.39 per share for the quarter.
Further, the company increased its full year earnings guidance to $5.40 to $5.50 per share from the prior range of $5.35 to $5.45.

For 2011, Praxair expects sales in the area of $11.2 billion. The previous projection was for sales in the area of $11 billion.

Wall Street expects 2011 earnings of $5.47 per share on revenues of $11.16 billion.

 

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.